Published in Clin Kidney J on June 17, 2014
Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy. J Am Soc Nephrol (1997) 1.71
Lipoprotein glomerulopathy: a new cause of nephrotic syndrome after renal transplantation. Nephrol Dial Transplant (1998) 1.43
Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia. Am J Kidney Dis (1989) 1.32
Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases. Am J Kidney Dis (2006) 1.16
A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy. Kidney Int (1999) 1.08
Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy. Nephron (1999) 0.97
Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits. Kidney Int (2008) 0.94
Apolipoprotein E2/E5 variants in lipoprotein glomerulopathy recurred in transplanted kidney. J Am Soc Nephrol (1999) 0.90
Lipoprotein glomerulopathy. Report of a normolipidemic case and review of the literature. Am J Nephrol (1993) 0.89
Recurrence of lipoprotein glomerulopathy after renal transplantation. Nephrol Dial Transplant (1997) 0.88
Common apolipoprotein E gene mutations contribute to lipoprotein glomerulopathy in China. Nephron Clin Pract (2010) 0.87
Topics in lipoprotein glomerulopathy: an overview. Clin Exp Nephrol (2013) 0.86
A rare cause of posttransplantation nephrotic syndrome. Am J Kidney Dis (2005) 0.80
Recurrence of fibrillary glomerulonephritis in a renal transplant recipient. Int Urol Nephrol (2012) 0.78